BioSpring GmbH is a Frankfurt-based oligonucleotide CDMO and global leader in nucleic acid manufacturing and analysis since 1997. The company specializes in manufacturing mRNA, siRNA, guide RNA, ASO, and other oligonucleotides across all clinical phases to commercial scale. BioSpring has invested over 100 million euros in a new large-scale production facility for nucleic acid-based therapeutics.
Oligonucleotide manufacturing, nucleic acid analysis, mRNA production, siRNA, ASO, guide RNA, GMP oligonucleotide synthesis
1 site worldwide
No reviews available yet.
No documents available.